The expression of the lymphatic endothelial cell marker LYVE-1 in benign and malignant vascular tumours

The expression of the lymphatic endothelial cell marker LYVE-1 in benign and malignant vascular tumours

Detalles Bibliográficos
Autores principales:	Edwards, J, Xu, H, Espinosa, O, Banerji, S, Jackson, D, Athanasou, N
Formato:	Conference item
Publicado:	2003

Ejemplares similares

Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors.
por: Xu, H, et al.
Publicado: (2004)

Intratumoural lymphatics in benign and malignant soft tissue tumours.
por: Mahendra, G, et al.
Publicado: (2008)

Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
por: Trojan, L, et al.
Publicado: (2004)

LYVE-1, the lymphatic system and tumor lymphangiogenesis.
por: Jackson, D, et al.
Publicado: (2001)

Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis.
por: Jackson, D
Publicado: (2004)

Distinctive properties of the hyaluronan-binding domain in the lymphatic endothelial receptor Lyve-1 and their implications for receptor function.
por: Banerji, S, et al.
Publicado: (2010)

Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium.
por: Prevo, R, et al.
Publicado: (2001)

Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor (LYVE-1) by ocular surface cells.
por: Chen, L, et al.
Publicado: (2004)

Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1.
por: Johnson, L, et al.
Publicado: (2007)

Binding of hyaluronan to the native lymphatic vessel endothelial receptor LYVE-1 is critically dependent on receptor clustering and hyaluronan organization
por: Lawrance, W, et al.
Publicado: (2016)

The cortical actin network regulates avidity-dependent binding of hyaluronan by the Lymphatic Vessel Endothelial receptor LYVE-1
por: Stanly, TA, et al.
Publicado: (2020)

Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1.
por: Gale, N, et al.
Publicado: (2007)

A mechanism of sialylation functionally silences the hyaluronan receptor LYVE-1 in lymphatic endothelium.
por: Nightingale, T, et al.
Publicado: (2009)

Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
por: Cursiefen, C, et al.
Publicado: (2002)

The role of lymphatics in tumour growth in bone
por: Edwards, JR, et al.
Publicado: (2004)

Malignant Presentation of Benign Tumour of the Rectum
por: Sanjeev Sandrasecra, et al.
Publicado: (2020)

Homodimerisation of the lymph vessel endothelial receptor LYVE-1 through a redox-labile disulfide is critical for hyaluronan binding in lymphatic endothelium
por: Banerji, S, et al.
Publicado: (2016)

Homodimerisation of the lymph vessel endothelial receptor LYVE-1 through a redox-labile disulfide is critical for hyaluronan binding in lymphatic endothelium
por: Banerji, S, et al.
Publicado: (2016)

The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1.
por: Jackson, D
Publicado: (2003)

Lymphatic markers, tumour lymphangiogenesis and lymph node metastasis.
por: Jackson, D
Publicado: (2007)

Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking
por: Jackson, D
Publicado: (2018)

Whole-genome methylation analysis of benign and malignant colorectal tumours.
por: Beggs, A, et al.
Publicado: (2013)

Whole-genome methylation analysis of benign and malignant colorectal tumours
por: Beggs, A, et al.
Publicado: (2013)

Distribution of lymphatic vessels in normal and arthritic human synovial tissues.
por: Xu, H, et al.
Publicado: (2003)

Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1
por: Johnson, L, et al.
Publicado: (2017)

Feline lymphangiosarcoma--definitive identification using a lymphatic vascular marker.
por: Galeotti, F, et al.
Publicado: (2004)

High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer.
por: Bono, P, et al.
Publicado: (2004)

A pilot study of power doppler sonography using tumour vascularity pattern in differentiating benign from malignant breast lesion
por: Said, Siti Nor Badriati Sheik
Publicado: (2006)

Rapid Lymphatic Dissemination of Encapsulated Group A Streptococci via Lymphatic Vessel Endothelial Receptor-1 Interaction
por: Lynskey, N, et al.
Publicado: (2015)

A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity.
por: Kato, T, et al.
Publicado: (2005)

Basement membrane protein distribution in LYVE-1-immunoreactive lymphatic vessels of normal tissues and ovarian carcinomas.
por: Vainionpää, N, et al.
Publicado: (2007)

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.
por: Mandriota, S, et al.
Publicado: (2001)

Lymphatic vessels are present in phosphaturic mesenchymal tumours.
por: Williams, K, et al.
Publicado: (2007)

A systematic review of malignant versus benign solitary fibrous tumours of the pleura (SFTP)
por: Mercer, R, et al.
Publicado: (2018)

Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues.
por: Cao, Y, et al.
Publicado: (2003)

Molecular characterization of lymphatic endothelial cells.
por: Podgrabinska, S, et al.
Publicado: (2002)

Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: correlation with pathologic parameters and clinical outcome.
por: Heinzelbecker, J, et al.
Publicado: (2013)

Bisphosphonate treatment of benign multifocal and unifocal osteolytic tumours of bone.
por: Gibbons, C, et al.
Publicado: (2003)

Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
por: Von Marschall, Z, et al.
Publicado: (2005)

Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
por: Karkkainen, M, et al.
Publicado: (2004)